{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:49:47Z","timestamp":1793890187751,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Astellas Pharma Inc."},{"name":"Taisho Pharma Co., Ltd."},{"DOI":"10.13039\/501100019949","name":"FUJIFILM Toyama Chemical","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019949","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current microbiological tests fail to identify the causative microorganism in more than half of all pneumonia cases. We explored biomarkers that could be used for differentiating between bacterial and viral pneumonia in patients with community-acquired pneumonia (CAP).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this prospective cohort study conducted in Japan, data obtained from adult patients with bacterial pneumonia, including bacterial and viral coinfections (bacterial pneumonia [BP] group), and purely viral pneumonia (VP group) at diagnosis were analyzed using multivariate logistic regression analysis to identify predictors of bacterial pneumonia. Furthermore, a decision tree was developed using the predictors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 210 patients were analyzed. The BP and VP groups comprised 108 and 18 patients, respectively. The other 84 patients had no identified causative microorganism. The two groups shared similar characteristics, including disease severity; however, a significant difference (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) was observed between the two groups regarding sputum type; sputum volume score; neutrophil counts; and serum levels of interleukin (IL)-8, IL-10, and \u03b11-antitrypsin (AAT). Sputum volume score (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), IL-10 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and AAT (<jats:italic>p<\/jats:italic>\u2009=\u20090.008) were ultimately identified as predictors of BP. The area under the curve for these three variables on the receiver operating characteristic (ROC) curve was 0.927 (95% confidence interval [CI]: 0.881\u20130.974). The ROC curve for sputum volume score and an AAT\/IL-10 ratio showed a diagnostic cutoff of 1\u2009+\u2009and 65, respectively. Logistic regression analysis using dichotomized variables at the cutoff values showed that the odds ratios for the diagnosis of BP were 10.4 (95% CI: 2.2\u201350.2) for sputum volume score (absence vs. presence) and 19.8 (95% CI: 4.7\u201383.2) for AAT\/IL-10 ratio (&lt;\u200965 vs.\u2009\u2265\u200965).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Considering that obtaining a definitive etiologic diagnosis with the current testing methods is difficult and time consuming, a decision tree with two predictors, namely sputum volume and the AAT\/IL-10 ratio, can be useful in predicting BP among patients diagnosed with CAP and facilitating the appropriate use of antibiotics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>UMIN000034673 registered on November 29, 2018.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41479-023-00118-4","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:02:02Z","timestamp":1698192122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A high \u03b11-antitrypsin\/interleukin-10 ratio predicts bacterial pneumonia in adults with community-acquired pneumonia: a prospective cohort study"],"prefix":"10.1186","volume":"15","author":[{"given":"Taiga","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoyasu","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyomitsu","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yatera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Futsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kosai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"key":"118_CR1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","volume":"398","author":"S Aliberti","year":"2021","unstructured":"Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI. Community-acquired pneumonia. Lancet. 2021;398:906\u201319.","journal-title":"Lancet"},{"key":"118_CR2","doi-asserted-by":"crossref","first-page":"e0001522","DOI":"10.1128\/cmr.00015-22","volume":"35","author":"NJ Gadsby","year":"2022","unstructured":"Gadsby NJ, Musher DM. The microbial etiology of community-acquired pneumonia in adults: from classical bacteriology to host transcriptional signatures. Clin Microbiol Rev. 2022;35:e0001522.","journal-title":"Clin Microbiol Rev"},{"key":"118_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","volume":"7","author":"A Torres","year":"2021","unstructured":"Torres A, Cilloniz C, Niederman MS, Men\u00e9ndez R, Chalmers JD, Wunderink RG, et al. Pneumonia Nat Rev Dis Primers. 2021;7:25.","journal-title":"Pneumonia Nat Rev Dis Primers"},{"key":"118_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18:95\u2013107.","journal-title":"Lancet Infect Dis"},{"key":"118_CR5","first-page":"CD007498","volume":"10","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:CD007498.","journal-title":"Cochrane Database Syst Rev"},{"key":"118_CR6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1802670","volume":"379","author":"DT Huang","year":"2018","unstructured":"Huang DT, Yealy DM, Filbin MR, Brown AM, Chang CH, Doi Y, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018;379:236\u201349.","journal-title":"N Engl J Med"},{"key":"118_CR7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MEJ.0000000000000796","volume":"28","author":"S Malinverni","year":"2021","unstructured":"Malinverni S, Nu\u00f1ez M, Cotton F, Martiny D, Collot V, Konopnicki D, et al. Is procalcitonin a reliable marker of bacterial community-acquired pneumonia in adults admitted to the emergency department during SARS-CoV-2 pandemic? Eur J Emerg Med. 2021;28:312\u20134.","journal-title":"Eur J Emerg Med"},{"key":"118_CR8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jinf.2022.06.024","volume":"85","author":"R Carbonell","year":"2022","unstructured":"Carbonell R, Urgel\u00e9s S, Salgado M, Rodr\u00edguez A, Reyes LF, Fuentes YV, et al. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients. J Infect. 2022;85:374\u201381.","journal-title":"J Infect"},{"key":"118_CR9","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45\u201367.","journal-title":"Am J Respir Crit Care Med."},{"key":"118_CR10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. Adults. N Engl J Med. 2015;373:415\u201327.","journal-title":"N Engl J Med."},{"key":"118_CR11","doi-asserted-by":"crossref","first-page":"00096","DOI":"10.1183\/23120541.00096-2018","volume":"4","author":"M Carugati","year":"2018","unstructured":"Carugati M, Aliberti S, Reyes LF, Franco Sadud R, Irfan M, Prat C, et al. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study. ERJ Open Res. 2018;4:00096\u20132018.","journal-title":"ERJ Open Res"},{"key":"118_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41479-020-00074-3","volume":"12","author":"S Shoar","year":"2020","unstructured":"Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan). 2020;12:11.","journal-title":"Pneumonia (Nathan)"},{"key":"118_CR13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.rmed.2011.02.002","volume":"105","author":"SM Janciauskiene","year":"2011","unstructured":"Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, K\u00f6hnlein T, Welte T. The discovery of \u03b11-antitrypsin and its role in health and disease. Respir Med. 2011;105:1129\u201339.","journal-title":"Respir Med"},{"key":"118_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-5793(94)80695-0","volume":"346","author":"P Venembre","year":"1994","unstructured":"Venembre P, Boutten A, Seta N, Dehoux MS, Crestani B, Aubier M, et al. Secretion of alpha 1-antitrypsin by alveolar epithelial cells. FEBS Lett. 1994;346:171\u20134.","journal-title":"FEBS Lett"},{"key":"118_CR15","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.2147\/COPD.S276792","volume":"15","author":"KBR Belchamber","year":"2020","unstructured":"Belchamber KBR, Walker EM, Stockley RA, Sapey E. Monocytes and macrophages in alpha-1 antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. 2020;15:3183\u201392.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"118_CR16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1515\/hsz-2014-0161","volume":"395","author":"MR Ehlers","year":"2014","unstructured":"Ehlers MR. Immune-modulating effects of alpha-1 antitrypsin. Biol Chem. 2014;395:1187\u201393.","journal-title":"Biol Chem"},{"key":"118_CR17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/rccm.201506-1100OC","volume":"193","author":"C Valim","year":"2016","unstructured":"Valim C, Ahmad R, Lanaspa M, Tan Y, Ac\u00e1cio S, Gillette MA, et al. Responses to bacteria, virus, and malaria distinguish the etiology of pediatric clinical pneumonia. Am J Respir Crit Care Med. 2016;193:448\u201359.","journal-title":"Am J Respir Crit Care Med"},{"key":"118_CR18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2019.00794","volume":"10","author":"R Porte","year":"2019","unstructured":"Porte R, Davoudian S, Asgari F, Parente R, Mantovani A, Garlanda C, Bottazzi B. The Long Pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Front Immunol. 2019;10:794.","journal-title":"Front Immunol"},{"key":"118_CR19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10156-002-0187-5","volume":"8","author":"A Saito","year":"2002","unstructured":"Saito A, Aoki N, Odagiri S, Niki Y, Yamaguchi K, Utada N, et al. Respiratory tract committee, protocol composition committee, clinical trial committee, Japanese society of chemotherapy. Committee Report: Clinical trial protocol for a new antimicrobial agent for the treatment of respiratory tract infections. J Infect Chemother. 2002;8:273\u2013319.","journal-title":"J Infect Chemother."},{"key":"118_CR20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/cid\/cix549","volume":"65","author":"DM Musher","year":"2017","unstructured":"Musher DM, Abers MS, Bartlett JG. Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus. Clin Infect Dis. 2017;65:1736\u201344.","journal-title":"Clin Infect Dis"},{"key":"118_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2017.07.019","volume":"95","author":"Y Alimi","year":"2017","unstructured":"Alimi Y, Lim WS, Lansbury L, Leonardi-Bee J, Nguyen-Van-Tam JS. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol. 2017;95:26\u201335.","journal-title":"J Clin Virol"},{"key":"118_CR22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/02813430902759663","volume":"27","author":"A Altiner","year":"2009","unstructured":"Altiner A, Wilm S, D\u00e4ubener W, Bormann C, Pentzek M, Abholz HH, et al. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand J Prim Health Care. 2009;27:70\u20133.","journal-title":"Scand J Prim Health Care"},{"key":"118_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1099\/jmm.0.067108-0","volume":"63","author":"EGW Huijskens","year":"2014","unstructured":"Huijskens EGW, Koopmans M, Palmen FMH, van Erkel AJM, Mulder PGH, Rossen JWA. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. J Med Microbiol. 2014;63:441\u201352.","journal-title":"J Med Microbiol"},{"key":"118_CR24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajem.2013.01.030","volume":"31","author":"JP Haran","year":"2013","unstructured":"Haran JP, Buglione-Corbett R, Lu S. Cytokine markers as predictors of type of respiratory infection in patients during the influenza season. Am J Emerg Med. 2013;31:816\u201321.","journal-title":"Am J Emerg Med"},{"key":"118_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","volume":"42","author":"L Lu","year":"2021","unstructured":"Lu L, Zhang H, Dauphars DJ, He YW. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol. 2021;42:3\u20135.","journal-title":"Trends Immunol"},{"key":"118_CR26","first-page":"1","volume":"97","author":"J Hedlund","year":"1995","unstructured":"Hedlund J. Community-acquired pneumonia requiring hospitalization. Factors of importance for the short-and long term prognosis. Scand J Infect Dis Suppl. 1995;97:1\u201360.","journal-title":"Scand J Infect Dis Suppl."},{"key":"118_CR27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/23744235.2022.2111464","volume":"54","author":"B Pertzov","year":"2022","unstructured":"Pertzov B, Shapira G, Abushkara S, Cohen S, Turjeman A, Kramer MR, et al. Lower serum alpha 1 antitrypsin levels in patients with severe COVID-19 compared with patients hospitalized due to non-COVID-19 pneumonia. Infect Dis (Lond). 2022;54:846\u201351.","journal-title":"Infect Dis (Lond)"},{"key":"118_CR28","unstructured":"National Institute for Health and Care Excellence. Pneumonia in adults: diagnosis and management (CG191). NICE, 2014 (Last Update: Jul 7, 2022)."},{"key":"118_CR29","unstructured":"National Institute for Health and Care Excellence. Pneumonia (community-acquired): antimicrobial prescribing (NG138). NICE, 2019."},{"key":"118_CR30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3399\/bjgp18X694901","volume":"68","author":"JW Cals","year":"2018","unstructured":"Cals JW, Ebell MH. C-reactive protein: guiding antibiotic prescribing decisions at the point of care. Br J Gen Pract. 2018;68:112\u20133.","journal-title":"Br J Gen Pract"},{"key":"118_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","volume":"174","author":"M Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R, M\u00fcller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006;174:84\u201393.","journal-title":"Am J Respir Crit Care Med"},{"key":"118_CR32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","volume":"371","author":"DM Musher","year":"2014","unstructured":"Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014;371:1619\u201328.","journal-title":"N Engl J Med"},{"key":"118_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/cid\/cix317","volume":"65","author":"WH Self","year":"2017","unstructured":"Self WH, Balk RA, Grijalva CG, Williams DJ, Zhu Y, Anderson EJ, et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis. 2017;65:183\u201390.","journal-title":"Clin Infect Dis"},{"key":"118_CR34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1473-3099(18)30215-9","volume":"18","author":"IS Kamat","year":"2018","unstructured":"Kamat IS, Ramachandran V, Eswaran H, Abers MS, Musher DM. Low procalcitonin, community acquired pneumonia, and antibiotic therapy. Lancet Infect Dis. 2018;18:496\u20137.","journal-title":"Lancet Infect Dis"},{"key":"118_CR35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/cid\/ciz545","volume":"70","author":"IS Kamat","year":"2020","unstructured":"Kamat IS, Ramachandran V, Eswaran H, Guffey D, Musher DM. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2020;70:538\u201342.","journal-title":"Clin Infect Dis"},{"key":"118_CR36","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.chest.2020.07.089","volume":"158","author":"MW Pletz","year":"2020","unstructured":"Pletz MW, Blasi F, Chalmers JD, Dela Cruz CS, Feldman C, Luna CM, et al. International Perspective on the New 2019 American Thoracic Society\/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: a critical appraisal by a global expert panel. Chest. 2020;158:1912\u20138.","journal-title":"Chest"},{"key":"118_CR37","doi-asserted-by":"crossref","first-page":"e0206527","DOI":"10.1371\/journal.pone.0206527","volume":"13","author":"I Yunus","year":"2018","unstructured":"Yunus I, Fasih A, Wang Y. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS ONE. 2018;13:e0206527.","journal-title":"PLoS ONE"},{"key":"118_CR38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.5858\/arpa.2020-0471-SA","volume":"144","author":"Y Tjendra","year":"2020","unstructured":"Tjendra Y, Al Mana AF, Espejo AP, Akgun Y, Millan NC, Gomez-Fernandez C, et al. Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers. Arch Pathol Lab Med. 2020;144:1465\u201374.","journal-title":"Arch Pathol Lab Med"},{"key":"118_CR39","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","volume":"127","author":"F Liu","year":"2020","unstructured":"Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370.","journal-title":"J Clin Virol"},{"key":"118_CR40","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1038\/s41598-023-30807-5","volume":"13","author":"E Kyriazopoulou","year":"2023","unstructured":"Kyriazopoulou E, Leventogiannis K, Tavoulareas G, Mainas E, Toutouzas K, Mathas C, et al. Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19. Sci Rep. 2023;13:3814.","journal-title":"Sci Rep"},{"key":"118_CR41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710\u20138.","journal-title":"Am J Epidemiol"},{"key":"118_CR42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/JCM.02787-13","volume":"52","author":"P Ruggiero","year":"2014","unstructured":"Ruggiero P, McMillen T, Tang YW, Babady NE. Evaluation of the BioFire FilmArray respiratory panel and the GenMark eSensor respiratory viral panel on lower respiratory tract specimens. J Clin Microbiol. 2014;52:288\u201390.","journal-title":"J Clin Microbiol"},{"key":"118_CR43","doi-asserted-by":"crossref","first-page":"e28317","DOI":"10.1002\/jmv.28317","volume":"95","author":"J Berastegui-Cabrera","year":"2023","unstructured":"Berastegui-Cabrera J, Aguilar-Guisado M, Crespo-Rivas JC, L\u00f3pez-Verdugo M, Merino L, Escoresca-Ortega A, et al. Prepandemic viral community-acquired pneumonia: Diagnostic sensitivity and specificity of nasopharyngeal swabs and performance of clinical severity scores. J Med Virol. 2023;95:e28317.","journal-title":"J Med Virol"},{"key":"118_CR44","doi-asserted-by":"crossref","first-page":"114880","DOI":"10.1016\/j.diagmicrobio.2019.114880","volume":"95","author":"K Locher","year":"2019","unstructured":"Locher K, Roscoe D, Jassem A, Wong T, Hoang LMN, Charles M, et al. FilmArray respiratory panel assay: an effective method for detecting viral and atypical bacterial pathogens in bronchoscopy specimens. Diagn Microbiol Infect Dis. 2019;95:114880.","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-023-00118-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-023-00118-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-023-00118-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T22:33:07Z","timestamp":1700605987000},"score":1,"resource":{"primary":{"URL":"https:\/\/pneumonia.biomedcentral.com\/articles\/10.1186\/s41479-023-00118-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1186\/s41479-023-00118-4","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been performed in accordance the tenets of the Helsinki Declaration and has been approved by each institutional review board or equivalent committee of the participating institutions. Written consent has been obtained from all individuals included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication has been obtained from all individuals included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}